Takeda Pharmaceutical (4502.T) Assets
Market Cap: $7.19T
Avg Volume: 4.10M
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Takeda Pharmaceutical Asset Metrics Summary
According to Takeda Pharmaceutical's latest annual financial reports, the company's asset profile is as follows:
Total Assets
Takeda Pharmaceutical's total assets amount to $15.11T. This is divided into:
- Total Current Assets: $2.56T
- Total Non-current Assets: $12.55T
- Net Receivables: $697.61B
- Inventory: $1.21T
- Cash and Short-term Investments: $457.80B
- Property, Plant, and Equipment (Net): $1.99T
- Long-term Investments: $430.61B
- Goodwill and Intangible Assets: $9.68T
Asset Ratios and Metrics
To better understand Takeda Pharmaceutical's asset management, we can look at several key ratios:
- Return on Assets (ROA): 0.95% - this indicates how profitable a company is relative to its total assets.
- Asset Turnover: 0.28 - this shows how efficiently a company uses its assets to generate sales.
- Current Ratio: 1.11 - this measures a company's ability to pay short-term obligations with its current assets.
- Quick Ratio: 0.58 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
- Cash Ratio: 0.20 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.
These metrics provide insight into Takeda Pharmaceutical's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.
Total Assets
$15.11T
Total Current Assets
$2.56T
Total Non-current Assets
$12.55T
Net Receivables
$697.61B
Inventory
$1.21T
Cash and Short-term Investments
$457.80B
Property, Plant, and Equipment (Net)
$1.99T
Long-term Investments
$430.61B
Goodwill and Intangible Assets
$9.68T
Return on Assets
0.95%
Asset Turnover
0.28
Current Ratio
1.11
Takeda Pharmaceutical Historical Asset Metrics
Historical Return on Assets
Historical Total Assets Growth
Takeda Pharmaceutical Historical Assets
The table below shows various asset metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Total Assets | Total Current Assets | Total Non-current Assets | Net Receivables | Inventory | Cash and Short-term Investments | Property, Plant, Equipment (Net) | Long-term Investments | Goodwill and Intangible Assets | Return on Assets | Asset Turnover | Current Ratio | Quick Ratio | Cash Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | $15.11T | $2.56T | $12.55T | $697.61B | $1.21T | $457.80B | $1.99T | $430.61B | $9.68T | 0.01 | 0.28 | 1.11 | 0.58 | 0.20 |
| 2022 | $13.96T | $2.40T | $11.56T | $681.69B | $986.46B | $553.70B | $1.69T | $378.86B | $9.06T | 0.02 | 0.29 | 0.97 | 0.57 | 0.21 |
| 2021 | $13.18T | $2.59T | $10.58T | $724.38B | $853.17B | $875.00B | $1.58T | $330.13B | $8.23T | 0.02 | 0.27 | 1.21 | 0.81 | 0.40 |
| 2020 | $12.91T | $2.71T | $10.20T | $812.71B | $753.88B | $1.00T | $1.45T | $348.35B | $7.94T | 0.03 | 0.25 | 1.53 | 1.10 | 0.54 |
| 2019 | $12.82T | $2.47T | $10.35T | $784.92B | $759.60B | $653.44B | $1.39T | $369.45B | $8.18T | 0.00 | 0.26 | 1.13 | 0.79 | 0.29 |
| 2018 | $13.87T | $3.05T | $10.82T | $749.12B | $986.74B | $725.37B | $1.32T | $306.90B | $9.02T | 0.01 | 0.15 | 1.21 | 0.82 | 0.28 |
| 2017 | $4.11T | $1.08T | $3.03T | $428.79B | $212.94B | $375.17B | $536.80B | $304.38B | $2.04T | 0.05 | 0.43 | 1.46 | 1.17 | 0.40 |
| 2016 | $4.36T | $1.26T | $3.10T | $444.78B | $226.29B | $376.14B | $530.15B | $303.05B | $2.09T | 0.03 | 0.40 | 0.92 | 0.76 | 0.23 |
| 2015 | $3.82T | $1.37T | $2.45T | $430.57B | $254.01B | $560.03B | $551.92B | $159.56B | $1.52T | 0.02 | 0.47 | 1.60 | 1.31 | 0.53 |
| 2014 | $4.30T | $1.52T | $2.78T | $466.83B | $262.35B | $713.42B | $526.16B | $251.75B | $1.76T | -0.03 | 0.41 | 1.49 | 1.24 | 0.64 |
Related Metrics
Explore detailed financial metrics and analysis for 4502.T.